Market revenue in 2023 | USD 742.0 million |
Market revenue in 2030 | USD 1,218.5 million |
Growth rate | 7.3% (CAGR from 2023 to 2030) |
Largest segment | Dogs |
Fastest growing segment | Cats |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Dogs, Cats |
Key market players worldwide | Merck & Co Inc, Zoetis, BD, Boehringer Ingelheim, ACON Laboratories, Taidoc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pet diabetes care market will help companies and investors design strategic landscapes.
Dogs was the largest segment with a revenue share of 52.01% in 2023. Horizon Databook has segmented the North America pet diabetes care market based on dogs, cats covering the revenue growth of each sub-segment from 2018 to 2030.
The high share can be attributed to the local presence of major market players, rising diagnostic rates & treatment availabilities for pet diabetes, and growing adoption of strategies initiated by key players to enhance market penetration.
For instance, on December 2022, Elanco launched Bexa cat tablets, a first-of-its-kind oral diabetes care formulation for cats.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America pet diabetes care market , including forecasts for subscribers. This continent databook contains high-level insights into North America pet diabetes care market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account